Pituitary deficiency after aneurysmal subarachnoid hemorrhage
OBJECTIVE: Aneurysmal subarachnoid hemorrhage puts patients at high risk for the development of pituitary insufficiency. We evaluated the incidence of pituitary dysfunction in these patients and its correlation with clinical outcome. METHODS: Pituitary function was tested in 66 consecutive patient...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Faculdade de Medicina / USP
2013-06-01
|
Series: | Clinics |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322013000600745 |
id |
doaj-506edf7d794148828a86d5b3ac853a22 |
---|---|
record_format |
Article |
spelling |
doaj-506edf7d794148828a86d5b3ac853a222020-11-24T22:24:33ZengFaculdade de Medicina / USPClinics1807-59321980-53222013-06-01686745749Pituitary deficiency after aneurysmal subarachnoid hemorrhageJulio Leonardo Barbosa PereiraLucas Alverne Freitas de AlbuquerqueMarcos DellarettiGervásio Teles Cardoso de CarvalhoGerival Vieira JrVitor Michelstaedter BrochadoAusten Venâncio DrummondJoyce Espeschit de MoraisLeticia Maia FerreiraPaulo Augusto Carvalho MirandaAtos Alves de SousaOBJECTIVE: Aneurysmal subarachnoid hemorrhage puts patients at high risk for the development of pituitary insufficiency. We evaluated the incidence of pituitary dysfunction in these patients and its correlation with clinical outcome. METHODS: Pituitary function was tested in 66 consecutive patients in the first 15 days after aneurysmal subarachnoid hemorrhage. The following were measured in all patients: thyroid-stimulating hormone, free thyroxine, triiodothyronine, luteinizing hormone, follicle-stimulating hormone, total testosterone (in males), estradiol (in females), prolactin, serum cortisol, plasma adrenocorticotropic hormone, growth hormone and insulin growth factor. RESULTS: The endocrine assessment was made at a mean of 7.4 days (standard deviation ±6.6) after subarachnoid hemorrhage. Forty-four (66.7%) female and 22 (33.3%) male patients were evaluated. Thirty-nine patients (59.1%) had some type of pituitary dysfunction. Follicle-stimulating hormone/luteinizing hormone deficiency was the most frequent disorder (34.8%), followed by growth hormone/insulin growth factor (28.7%), adrenocorticotropic hormone (18.1%) and thyroid-stimulating hormone (9%). Seventeen (25.7%) patients showed deficiencies in more than one axis. A greater incidence of hormone deficiency was observed in patients with a Glasgow Coma Scale score ≤13 (t test, p = 0.008), Hunt-Hess grade ≥4 (t test, p<0.001), or Fisher grade 4 (t test, p = 0.039). Hormone deficiency was not significantly associated (p>0.05) with increased hospitalization or clinical outcome. CONCLUSION: Pituitary dysfunction was identified in a substantial portion of patients with previous aneurysmal subarachnoid hemorrhage, but no association was found between this dysfunction and poor clinical outcome.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322013000600745Subarachnoid HemorrhageEndocrine DysfunctionAneurysm |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Julio Leonardo Barbosa Pereira Lucas Alverne Freitas de Albuquerque Marcos Dellaretti Gervásio Teles Cardoso de Carvalho Gerival Vieira Jr Vitor Michelstaedter Brochado Austen Venâncio Drummond Joyce Espeschit de Morais Leticia Maia Ferreira Paulo Augusto Carvalho Miranda Atos Alves de Sousa |
spellingShingle |
Julio Leonardo Barbosa Pereira Lucas Alverne Freitas de Albuquerque Marcos Dellaretti Gervásio Teles Cardoso de Carvalho Gerival Vieira Jr Vitor Michelstaedter Brochado Austen Venâncio Drummond Joyce Espeschit de Morais Leticia Maia Ferreira Paulo Augusto Carvalho Miranda Atos Alves de Sousa Pituitary deficiency after aneurysmal subarachnoid hemorrhage Clinics Subarachnoid Hemorrhage Endocrine Dysfunction Aneurysm |
author_facet |
Julio Leonardo Barbosa Pereira Lucas Alverne Freitas de Albuquerque Marcos Dellaretti Gervásio Teles Cardoso de Carvalho Gerival Vieira Jr Vitor Michelstaedter Brochado Austen Venâncio Drummond Joyce Espeschit de Morais Leticia Maia Ferreira Paulo Augusto Carvalho Miranda Atos Alves de Sousa |
author_sort |
Julio Leonardo Barbosa Pereira |
title |
Pituitary deficiency after aneurysmal subarachnoid hemorrhage |
title_short |
Pituitary deficiency after aneurysmal subarachnoid hemorrhage |
title_full |
Pituitary deficiency after aneurysmal subarachnoid hemorrhage |
title_fullStr |
Pituitary deficiency after aneurysmal subarachnoid hemorrhage |
title_full_unstemmed |
Pituitary deficiency after aneurysmal subarachnoid hemorrhage |
title_sort |
pituitary deficiency after aneurysmal subarachnoid hemorrhage |
publisher |
Faculdade de Medicina / USP |
series |
Clinics |
issn |
1807-5932 1980-5322 |
publishDate |
2013-06-01 |
description |
OBJECTIVE: Aneurysmal subarachnoid hemorrhage puts patients at high risk for the development of pituitary insufficiency. We evaluated the incidence of pituitary dysfunction in these patients and its correlation with clinical outcome. METHODS: Pituitary function was tested in 66 consecutive patients in the first 15 days after aneurysmal subarachnoid hemorrhage. The following were measured in all patients: thyroid-stimulating hormone, free thyroxine, triiodothyronine, luteinizing hormone, follicle-stimulating hormone, total testosterone (in males), estradiol (in females), prolactin, serum cortisol, plasma adrenocorticotropic hormone, growth hormone and insulin growth factor. RESULTS: The endocrine assessment was made at a mean of 7.4 days (standard deviation ±6.6) after subarachnoid hemorrhage. Forty-four (66.7%) female and 22 (33.3%) male patients were evaluated. Thirty-nine patients (59.1%) had some type of pituitary dysfunction. Follicle-stimulating hormone/luteinizing hormone deficiency was the most frequent disorder (34.8%), followed by growth hormone/insulin growth factor (28.7%), adrenocorticotropic hormone (18.1%) and thyroid-stimulating hormone (9%). Seventeen (25.7%) patients showed deficiencies in more than one axis. A greater incidence of hormone deficiency was observed in patients with a Glasgow Coma Scale score ≤13 (t test, p = 0.008), Hunt-Hess grade ≥4 (t test, p<0.001), or Fisher grade 4 (t test, p = 0.039). Hormone deficiency was not significantly associated (p>0.05) with increased hospitalization or clinical outcome. CONCLUSION: Pituitary dysfunction was identified in a substantial portion of patients with previous aneurysmal subarachnoid hemorrhage, but no association was found between this dysfunction and poor clinical outcome. |
topic |
Subarachnoid Hemorrhage Endocrine Dysfunction Aneurysm |
url |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322013000600745 |
work_keys_str_mv |
AT julioleonardobarbosapereira pituitarydeficiencyafteraneurysmalsubarachnoidhemorrhage AT lucasalvernefreitasdealbuquerque pituitarydeficiencyafteraneurysmalsubarachnoidhemorrhage AT marcosdellaretti pituitarydeficiencyafteraneurysmalsubarachnoidhemorrhage AT gervasiotelescardosodecarvalho pituitarydeficiencyafteraneurysmalsubarachnoidhemorrhage AT gerivalvieirajr pituitarydeficiencyafteraneurysmalsubarachnoidhemorrhage AT vitormichelstaedterbrochado pituitarydeficiencyafteraneurysmalsubarachnoidhemorrhage AT austenvenanciodrummond pituitarydeficiencyafteraneurysmalsubarachnoidhemorrhage AT joyceespeschitdemorais pituitarydeficiencyafteraneurysmalsubarachnoidhemorrhage AT leticiamaiaferreira pituitarydeficiencyafteraneurysmalsubarachnoidhemorrhage AT pauloaugustocarvalhomiranda pituitarydeficiencyafteraneurysmalsubarachnoidhemorrhage AT atosalvesdesousa pituitarydeficiencyafteraneurysmalsubarachnoidhemorrhage |
_version_ |
1725760738318876672 |